主页
市场
图表与思路
Algo
新闻
商店
经纪商
下载
经济日历
交易信号
网页端
热图
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
GNOM
#10123
Global X Genomics & Biotechnology ETF
46.4
2
USD
+4.08%
版块:
金融
基础:
USD
利润货币:
USD
日范围
年范围
日变化
+4.08%
每月变动
+5.67%
6个月变化
+0.26%
年变化
+0.26%
前一天收盘价
44.6
0
开盘价
46.5
2
买价
卖价
最低价
46.4
2
High
46.5
2
交易量
3
市场
股票
金融
GNOM
展开完整图表
主要持股
Market Value
Shares
Weight %
GH
GUARDANT HEALTH, INC.
3.08 M
28.41 K
5.65%
ILMN
ILLUMINA, INC.
2.84 M
21.60 K
5.21%
ARWR
ARROWHEAD PHARMACEUTICALS, INC.
2.69 M
50.96 K
4.92%
NTRA
NATERA, INC.
2.54 M
10.65 K
4.66%
BMRN
BIOMARIN PHARMACEUTICAL INC.
2.21 M
39.59 K
4.06%
MRNA
MODERNA, INC.
2.16 M
83.12 K
3.96%
TECH
BIO-TECHNE CORPORATION
2.14 M
33.10 K
3.92%
VRTX
VERTEX PHARMACEUTICALS INCORPORATED
2.13 M
4 921.00
3.91%
RNA
Avidity Biosciences Inc
2.11 M
29.48 K
3.88%
Qiagen N.V.
2.08 M
43.51 K
3.81%
PRAX
Praxis Precision Medicines Inc
2.06 M
10.49 K
3.78%
BNTX
BioNTech SE
2.05 M
19.86 K
3.76%
WGS
GeneDx Holdings Corp
2.04 M
12.19 K
3.73%
ALNY
ALNYLAM PHARMACEUTICALS, INC.
1.92 M
4 263.00
3.53%
LEGN
Legend Biotech Corp
1.77 M
63.90 K
3.25%
CRISPR Therapeutics AG
1.75 M
32.82 K
3.22%
VCYT
Veracyte Inc
1.75 M
37.01 K
3.21%
RARE
Ultragenyx Pharmaceutical Inc
1.50 M
43.14 K
2.75%
LLY
ELI LILLY AND COMPANY
1.36 M
1 262.00
2.49%
BMY
BRISTOL-MYERS SQUIBB COMPANY
1.19 M
24.10 K
2.17%
新闻
AI And The Future Of Healthcare
Global PMI: Tracking The Sectors Hit Hardest By The Middle East War
Can Forgotten Biotech Break Out?
Concerns Shift From Obsolescence To Oil
CDT Insider Sentiment March 2026: The Probability Race And Barbell Strategies
IBBQ, GNOM, BIB: Biotech ETFs Offer Exposure to Healthcare Startup Companies - TipRanks.com
Finally Coming Into View? 'Old-Economy' Stocks Show Their Colors
Q4 2025 Earnings: AI Disruption Vs. Traditional Fundamentals
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave
The K-Shaped Consumer Economy: GLP-1s, AI And The Future Of Consumer Spending
The Trump Administration’s Affordability Plan